Targeting Oncoprotein Translation with Rocaglates in MYC-Driven Lymphoma

被引：2
|
作者：
Zhang, Xuan [1 ]
Bi, Chengfeng [1 ]
Lu, Ting [2 ]
Yue, Ting [3 ]
Zhang, Weiwei [1 ]
Zhang, Xiaoyan [4 ]
Cheng, Wang [1 ]
Tian, Tian [1 ]
Lunning, Matthew A. [1 ]
Vose, Julie M. [1 ]
Pelletier, Jerry [5 ]
Porco, John A., Jr. [6 ]
Tao, Jianguo [7 ]
Fu, Kai [1 ]
机构：
[1] Univ Nebraska Med Ctr, Omaha, NE USA
[2] City Hope Natl Med Ctr, Duarte, CA USA
[3] Shanghai Jiao Tong Univ, Sch Med, Shanghai, Peoples R China
[4] China Yixueke Xueyuan Hemopathy Hosp, Tianjin, Peoples R China
[5] McGill Univ, Montreal, PQ, Canada
[6] Boston Univ, Boston, MA 02215 USA
[7] H Lee Moffitt Canc Ctr & Res Inst, Tampa, FL USA
来源：
BLOOD | 2018年 / 132卷
关键词：
D O I：
10.1182/blood-2018-99-117659
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
38
引用
收藏
页数：3
相关论文
共 50 条
  • [31] Efficacy of CHK inhibitors as single agents in MYC-driven lymphoma cells
    P T Ferrao
    E P Bukczynska
    R W Johnstone
    G A McArthur
    Oncogene, 2012, 31 : 1661 - 1672
  • [32] TARGETING DNA DAMAGE REPAIR IN MYC-DRIVEN PEDIATRIC BRAIN TUMORS
    Krausert, Sonja
    Lambo, Sander
    Brabetz, Sebastian
    Mack, Norman
    Schwalm, Benjamin
    Pfister, Stefan
    Kool, Marcel
    NEURO-ONCOLOGY, 2019, 21 : 114 - 114
  • [33] Targeting the SAGA and ATAC Transcriptional Coactivator Complexes in MYC-Driven Cancers
    Mustachio, Lisa Maria
    Roszik, Jason
    Farria, Aimee
    Dent, Sharon Y. R.
    CANCER RESEARCH, 2020, 80 (10) : 1905 - 1911
  • [34] Targeting Myc-driven stress vulnerability in mutant KRAS colorectal cancer
    Hang Ruan
    Brian J. Leibowitz
    Yingpeng Peng
    Lin Shen
    Lujia Chen
    Charlie Kuang
    Robert E. Schoen
    Xinghua Lu
    Lin Zhang
    Jian Yu
    Molecular Biomedicine, 3
  • [35] Targeting Myc-driven stress vulnerability in mutant KRAS colorectal cancer
    Ruan, Hang
    Leibowitz, Brian J.
    Peng, Yingpeng
    Shen, Lin
    Chen, Lujia
    Kuang, Charlie
    Schoen, Robert E.
    Lu, Xinghua
    Zhang, Lin
    Yu, Jian
    MOLECULAR BIOMEDICINE, 2022, 3 (01):
  • [36] Therapeutic targeting of MYC-driven prostate cancer by PIM kinase inhibition
    Abdulkadir, Sarki
    INTERNATIONAL JOURNAL OF MOLECULAR MEDICINE, 2016, 38 : S7 - S7
  • [37] SYNERGISTIC TARGETING OF CDK8 AND MTOR FOR MYC-DRIVEN MEDULLOBLASTOMA
    Wang, Dong
    Ritz, Caitlin
    Luo, Yuhuan
    Veo, Bethany
    Pierce, Angela
    Vibhakar, Rajeev
    NEURO-ONCOLOGY, 2024, 26
  • [38] IBTK Haploinsufficiency Affects the Tumor Microenvironment of Myc-Driven Lymphoma in E-myc Mice
    Vecchio, Eleonora
    Fiume, Giuseppe
    Mignogna, Chiara
    Iaccino, Enrico
    Mimmi, Selena
    Maisano, Domenico
    Trapasso, Francesco
    Quinto, Ileana
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2020, 21 (03)
  • [39] PHGDH is required for germinal center formation and is a therapeutic target in MYC-driven lymphoma
    D'Avola, Annalisa
    Legrave, Nathalie
    Tajan, Mylene
    Chakravarty, Probir
    Shearer, Ryan L.
    King, Hamish W.
    Kluckova, Katarina
    Cheung, Eric C.
    Clear, Andrew J.
    Gunawan, Arief S.
    Zhang, Lingling
    James, Louisa K.
    MacRae, James, I
    Gribben, John G.
    Calado, Dinis P.
    Vousden, Karen H.
    Riches, John C.
    JOURNAL OF CLINICAL INVESTIGATION, 2022, 132 (09):
  • [40] Therapeutic targeting nudix hydrolase 1 creates a MYC-driven metabolic vulnerability
    Ye, Minhui
    Fang, Yingzhe
    Chen, Lu
    Song, Zemin
    Bao, Qing
    Wang, Fei
    Huang, Hao
    Xu, Jin
    Wang, Ziwen
    Xiao, Ruijing
    Han, Meng
    Gao, Song
    Liu, Hudan
    Jiang, Baishan
    Qing, Guoliang
    NATURE COMMUNICATIONS, 2024, 15 (01)
12345